
Hey, this is pharma marketing. This is about making lives better. So get off Twitter and treat it seriously!
(Aug 4, 2010)*Why are we willing to pay more for our cellphones than for our health insurance?*
(Aug 9, 2010)Instead of avoiding PR disasters, it's about time we started talking about the fantastic achievements of the industry.
(Aug 9, 2010)*Want to devise a better marketing campaign? Shut up and listen.*
(Aug 15, 2010)Honesty is the best policy - on a CV and in the pharma business.
(Aug 16, 2010)*Near enough is not good enough when we are marketing health*
(Aug 17, 2010)Why a little dose of fear is good for compliance.
(Aug 23, 2010)If you want to give your product extra horsepower, get involved in the development.
(Sep 6, 2010)Key opinion leaders should be guides and counsels, not company junkies
(Sep 16, 2010)What pharma marketing needs now is an emotionally uplifting campaign that will explode onto the primary care scene
(Oct 5, 2010)Kevin Appareti, global director for Medical Science Liaison at Philips Healthcare, explains how to motivate KOLs and how to measure their value
The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs